CN107335090B - 一种具有创面修复作用的生物相容性止血材料及其制备方法 - Google Patents
一种具有创面修复作用的生物相容性止血材料及其制备方法 Download PDFInfo
- Publication number
- CN107335090B CN107335090B CN201710558877.6A CN201710558877A CN107335090B CN 107335090 B CN107335090 B CN 107335090B CN 201710558877 A CN201710558877 A CN 201710558877A CN 107335090 B CN107335090 B CN 107335090B
- Authority
- CN
- China
- Prior art keywords
- starch
- parts
- based nanoparticles
- solution
- genipin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000000463 material Substances 0.000 title abstract description 27
- 230000002439 hemostatic effect Effects 0.000 title abstract description 26
- 230000000694 effects Effects 0.000 title abstract description 23
- 230000037314 wound repair Effects 0.000 title abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 84
- 235000019698 starch Nutrition 0.000 claims abstract description 84
- 239000008107 starch Substances 0.000 claims abstract description 84
- 239000002105 nanoparticle Substances 0.000 claims abstract description 40
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims abstract description 19
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims abstract description 19
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 18
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 18
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 18
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 claims abstract description 18
- 238000004132 cross linking Methods 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 9
- 238000005189 flocculation Methods 0.000 claims description 7
- 230000016615 flocculation Effects 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 238000005453 pelletization Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 230000023597 hemostasis Effects 0.000 abstract description 18
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 30
- 206010052428 Wound Diseases 0.000 description 26
- 208000027418 Wounds and injury Diseases 0.000 description 25
- 229920001592 potato starch Polymers 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 10
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 8
- 229920002261 Corn starch Polymers 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000031969 Eye Hemorrhage Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960000182 blood factors Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000005161 hepatic lobe Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/624—Nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710558877.6A CN107335090B (zh) | 2017-07-11 | 2017-07-11 | 一种具有创面修复作用的生物相容性止血材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710558877.6A CN107335090B (zh) | 2017-07-11 | 2017-07-11 | 一种具有创面修复作用的生物相容性止血材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107335090A CN107335090A (zh) | 2017-11-10 |
CN107335090B true CN107335090B (zh) | 2020-09-01 |
Family
ID=60219789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710558877.6A Expired - Fee Related CN107335090B (zh) | 2017-07-11 | 2017-07-11 | 一种具有创面修复作用的生物相容性止血材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107335090B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102302796A (zh) * | 2011-09-08 | 2012-01-04 | 江苏天麟生物医药科技有限公司 | 吸收性止血生物材料及制备方法 |
CN102740862A (zh) * | 2009-12-04 | 2012-10-17 | 美格乐控股公司 | 具有内源性带电配体的水解淀粉微球 |
CN104606723A (zh) * | 2014-12-12 | 2015-05-13 | 重庆联佰博超医疗器械有限公司 | 可吸收性淀粉止血粉及其制备方法、应用 |
CN104888263A (zh) * | 2008-01-14 | 2015-09-09 | 纪欣 | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 |
CN105778126A (zh) * | 2016-03-31 | 2016-07-20 | 中国人民解放军军事医学科学院野战输血研究所 | 一种京尼平交联生物凝胶及其制备方法与应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000027327A1 (en) * | 1998-11-12 | 2000-05-18 | Polymer Biosciences, Inc. | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
-
2017
- 2017-07-11 CN CN201710558877.6A patent/CN107335090B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104888263A (zh) * | 2008-01-14 | 2015-09-09 | 纪欣 | 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料 |
CN102740862A (zh) * | 2009-12-04 | 2012-10-17 | 美格乐控股公司 | 具有内源性带电配体的水解淀粉微球 |
CN102302796A (zh) * | 2011-09-08 | 2012-01-04 | 江苏天麟生物医药科技有限公司 | 吸收性止血生物材料及制备方法 |
CN104606723A (zh) * | 2014-12-12 | 2015-05-13 | 重庆联佰博超医疗器械有限公司 | 可吸收性淀粉止血粉及其制备方法、应用 |
CN105778126A (zh) * | 2016-03-31 | 2016-07-20 | 中国人民解放军军事医学科学院野战输血研究所 | 一种京尼平交联生物凝胶及其制备方法与应用 |
Non-Patent Citations (1)
Title |
---|
新型淀粉基止血材料的制备及生物相容性研究;王艳玲;《生物医学工程研究》;20150615;第34卷(第2期);第102-105页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107335090A (zh) | 2017-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cao et al. | Injectable drug-loaded polysaccharide hybrid hydrogels for hemostasis | |
Pang et al. | Mechanically and functionally strengthened tissue adhesive of chitin whisker complexed chitosan/dextran derivatives based hydrogel | |
CN1288197C (zh) | 透明质酸凝胶组合物、其制造方法及含该组合物的医用材料 | |
CN109125791B (zh) | 一种具有促进骨修复功能的可吸收骨蜡及制备方法 | |
JP5835751B2 (ja) | 医療用吸収性骨創傷止血材及びその調製方法 | |
CN107551312B (zh) | 一种絮状胶原止血纤维及其制备方法 | |
CN105031711B (zh) | 一种胶原/壳聚糖复合海绵生物敷料及其制备方法 | |
KR101678402B1 (ko) | 창상치료용 알긴산 하이드로젤 및 그 제조방법 | |
WO2011018995A1 (ja) | 有機無機複合ヒドロゲルおよびその製造方法 | |
Zhang et al. | A highly transparent, elastic, injectable sericin hydrogel induced by ultrasound | |
Chen et al. | Study on the cross-linking effect of a natural derived oxidized chitosan oligosaccharide on the porcine acellular dermal matrix | |
KR101980063B1 (ko) | 히알루론산을 포함하는 스펀지형 생분해성 지혈제 조성물 | |
KR20130123080A (ko) | 히알루론산 에폭사이드 가교체 및 그 제조방법 | |
CN111068098A (zh) | 一种高强度聚乙烯醇水凝胶膜的制备方法 | |
Zhang et al. | An injectable serotonin–chondroitin sulfate hydrogel for bio-inspired hemostatic adhesives with high wound healing capability | |
KR20200008602A (ko) | 섬유화 무세포 진피 기질 및 생체적합성 고분자를 포함하는 조성물 및 이의 제조 방법 | |
KR20190007826A (ko) | 주입형 온도감응성 목재 기반 산화 나노 셀룰로오스를 포함한 유착 방지제 | |
Yang et al. | In situ exfoliated silk fibroin nanoribbons enhanced chitin hydrogel for bile duct restoration | |
CN106975098B (zh) | 一种复合多糖止血组合物及其制备方法与应用 | |
Rizwan et al. | Novel chitosan derivative based composite scaffolds with enhanced angiogenesis; potential candidates for healing chronic non-healing wounds | |
Ramzan et al. | Zinc oxide loaded chitosan-elastin-sodium alginate nanocomposite gel using freeze gelation for enhanced adipose stem cell proliferation and antibacterial properties | |
CN107823699A (zh) | 止血防粘连膜及其制备方法 | |
CN109432487A (zh) | 一种具有骨修复功能的骨蜡及其制备方法和应用 | |
CN107335090B (zh) | 一种具有创面修复作用的生物相容性止血材料及其制备方法 | |
JP7320078B2 (ja) | バイオセルロース繊維、それを含む止血用被覆材及び関連応用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Xuqi Inventor after: Xu Qinhong Inventor after: Wei Guangbing Inventor after: Wang Yan Inventor after: Hu Junxi Inventor after: Fan Xing Inventor before: Wang Yan Inventor before: Hu Junxi Inventor before: Fan Xing |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200804 Address after: 710061, Yanta Road, Yanta District, Shaanxi, 277, Xi'an Applicant after: Li Xuqi Address before: 211198 No. 1009 Tianyuan East Road, High-tech Park, Jiangning District, Nanjing City, Jiangsu Province Applicant before: NANJING XUHANG BIOLOGICAL MATERIAL TECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210825 Address after: 710061 No. 277, Yanta West Road, Shaanxi, Xi'an Patentee after: THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XI'AN JIAOTONG University Address before: 710061, Yanta Road, Yanta District, Shaanxi, 277, Xi'an Patentee before: Li Xuqi |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200901 |
|
CF01 | Termination of patent right due to non-payment of annual fee |